NL-OMON50905已完成不适用
SARS-CoV-2 specific immunity in patients with congenital immune deficiencies - SARS-CoV-2 immUNity in immune deficieNcY (SUNNY)
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •- 18 years or older
- •- congenital immune disorder for with they are monitored at the Infectious
- •Diseases outpatient clinic of the LUMC
- •- PCR-confirmed COVID-19 in the past or present
排除标准
- •- received a covid-19 vaccination before start of the study, regardless of the
- •type of vaccine or vaccine manufacturer
研究者
相似试验
进行中（未招募）
1 期
Response to corona vaccination in patients with primary Sjögren's syndromePrimary Sjögren's syndromeEUCTR2021-001414-10-NLniversity Medical Center Groningen180
已完成
4 期
Vaccine response against SARS-CoV-2 in patients with primary Sjögren*s syndrome1000381610047438Sjögren's syndromeNL-OMON51179niversitair Medisch Centrum Groningen180
已完成
Unknown
T2B! immunity after SARS-CoV-2<p>SARS-CoV-2, auto-immune diseases,</p>10003816NL-OMON23600ZonMw3,361
招募中
不适用
Immunity against SARS-CoV-2 in immune-suppressed patients: increased risk of insufficient immunological memory or sufficient protection against re-infection? A Target to B! substudyhematologische en andere B-cel gemedieerde aandoeningenimmunityimmunosuppressive medicationSARS-CoV-2 infection1000381610047438NL-OMON55289Academisch Medisch Centrum5,350
招募中
不适用
Immunogenicity against SARS-CoV-2 variants of concern of ChAdOx1 nCoV-19 vaccine, Sinovac's CoronaVac vaccine, heterologous vaccines and the third boosting vaccine in the elderly and COPD patientsCOPD,post SAR-COV-2 (COVID-19 virus) infectionHealthy elderlyCOPD,post SAR-COV-2 (COVID-19 virus) infectionHealthy elderly,COVID-19,immunologyTCTR20210822002Faculty of Medicine, Chiang Mai University150